Enantiodivergent synthesis of (R)- and (S)-rolipram

被引:37
作者
Demnitz, J [1 ]
LaVecchia, L [1 ]
Bacher, E [1 ]
Keller, TH [1 ]
Muller, T [1 ]
Schurch, F [1 ]
Weber, HP [1 ]
Pombo-Villar, E [1 ]
机构
[1] Novartis Pharma Ltd, Preclin Res, CH-4002 Basel, Switzerland
关键词
rolipram; phosphodiesterase; circular dichroism (CD) spectra; enantiodivergent synthesis;
D O I
10.3390/30300107
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Both enantiomers of rolipram (1) have been prepared in large quantity from a common intermediate rac-3-(3'-cyclopentyloxy-4'-methoxy)phenyl-4-nitro butyric acid (6), which was resolved by way of the two readily separable diastereoisomeric amides obtained with (S)-(-)-phenylethylamine. Reduction of the nitro group and intramolecular transamidation gave (R)-(-)-1 and (S)-(+)-1, respectively. CD spectra of both enantiomers of rolipram are reported and discussed. Both enantiomers of rolipram presented the same potency of inhibitory activity against recombinant cyclic-AMP-selective phosphodiesterase (PDE4) subtypes.
引用
收藏
页码:107 / 119
页数:13
相关论文
共 46 条
[1]  
BACKSTROM R, 1991, Patent No. 9116303
[2]   THE CRYSTAL-STRUCTURE, ABSOLUTE-CONFIGURATION, AND PHOSPHODIESTERASE INHIBITORY ACTIVITY OF (+)-1-(4-BROMOBENZYL)-4-(3-(CYCLOPENTYLOXY)-4-METHOXYPHENYL)-PYRROLIDIN-2-ONE [J].
BAURES, PW ;
EGGLESTON, DS ;
ERHARD, KF ;
CIESLINSKI, LB ;
TORPHY, TJ ;
CHRISTENSEN, SB .
JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (22) :3274-3277
[3]   PRIMARY SEQUENCE OF CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE ISOZYMES AND THE DESIGN OF SELECTIVE INHIBITORS [J].
BEAVO, JA ;
REIFSNYDER, DH .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1990, 11 (04) :150-155
[4]  
BENDER PE, 1986, J LIQ CHROMATOGRAPHY, V9, P341
[5]   DESIGN AND SYNTHESIS OF CONFORMATIONALLY CONSTRAINED ANALOGS OF 4-(3-BUTOXY-4-METHOXYBENZYL)IMIDAZOLIDIN-2-ONE (RO-20-1724) AS POTENT INHIBITORS OF CAMP-SPECIFIC PHOSPHODIESTERASE [J].
BRACKEEN, MF ;
COWAN, DJ ;
STAFFORD, JA ;
SCHOENEN, FJ ;
VEAL, JM ;
DOMANICO, PL ;
ROSE, D ;
STRICKLAND, AB ;
VERGHESE, M ;
FELDMAN, PL .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (24) :4848-4854
[6]  
BRAUN M, 1995, SYNLETT, P1174
[7]   THERAPEUTIC USE OF A SELECTIVE CAMP PHOSPHODIESTERASE INHIBITOR (ROLIPRAM) IN PARKINSONS-DISEASE [J].
CASACCHIA, M ;
MECO, G ;
CASTELLANA, F ;
BEDINI, L ;
CUSIMANO, G ;
AGNOLI, A .
PHARMACOLOGICAL RESEARCH COMMUNICATIONS, 1983, 15 (03) :329-334
[8]  
Christensen S.B., 1996, PHOSPHODIESTERASE IN, P185
[9]  
DEMNITZ J, UNPUB
[10]  
Demyanovich VM, 1996, KHIM GETEROTSIKL+, P944